• Medication Review: What is the clinical profile of Resmetirom, including dosing schedules?

  • Oct 3 2024
  • Duración: 3 m
  • Podcast

Medication Review: What is the clinical profile of Resmetirom, including dosing schedules?

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Thank you to Madrigal for sponsoring this Medication Review Video Module!

    In this GHAPP Medication Review Video Module, nurse practitioner Whitney Steinmetz discusses the clinical profile of Resmetirom, a thyroid hormone receptor beta agonist indicated for adults with metabolic-associated steatohepatitis (MASH) and moderate to advanced liver fibrosis. Whitney explores the mechanism of action, dosage recommendations, and the dual primary endpoint success of Resmetirom in clinical trials. She highlights key considerations, including drug interactions and common side effects such as nausea and diarrhea, and how they are generally well-tolerated over time. Learn more about Resmetirom's impact on liver health and patient care by visiting the GHAPP website or app.
    Más Menos
activate_Holiday_promo_in_buybox_DT_T2
Más Menos

Lo que los oyentes dicen sobre Medication Review: What is the clinical profile of Resmetirom, including dosing schedules?

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles